Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P.E., Zhou, X., Li, C., Shen, G., Zou, Bingwen, NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Signal Transduction and Targeted Therapy
These experimental compounds represent a dangerous gamble with long-term health
The 4 to 6 hour half-life of BPC-157 means single daily doses create peaks and troughs, while split dosing smooths out this variation
Swirl gently until dissolved and never shake or vortex
- GHK-Cu is a cGMP capsule research product containing 2MG per capsule with 60 capsules per bottle , providing 120MG total GHK-Cu content